mafosfamide has been researched along with Leukemia, Myeloid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hassan, HT | 1 |
| Rowley, SD | 1 |
| Buschfort, C; Müller, MR; Rajewsky, MF; Seeber, S; Seiler, F; Thomale, J | 1 |
| Bruecher, J; Claudé, R; Hoelzer, D; Martin, H | 1 |
| Fouillard, L; Gorin, NC; Isnard, F; Jouet, JP; Laporte, JP; Lesage, S; Michailov, G; Najman, A; Noel-Walter, MP | 1 |
| Bouchet, S; Douay, L; Giarratana, MC; Gorin, NC; Harnois, C; Laporte, JP; Lopez, M; Yao, M | 1 |
| Bader, P; Brugger, W; Grünebach, F; Kanz, L; Scheding, S; Stilz, R; Vogel, W | 1 |
| Bonati, A; Carlo-Stella, C; Mangoni, L; Rizzoli, V | 1 |
1 review(s) available for mafosfamide and Leukemia, Myeloid
| Article | Year |
|---|---|
Hematopoietic growth factors: in vitro and in vivo studies in bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Colony-Stimulating Factors; Cyclophosphamide; Hematopoiesis; Humans; In Vitro Techniques; Leukemia, Myeloid; Neutropenia; Transplantation, Autologous | 1990 |
7 other study(ies) available for mafosfamide and Leukemia, Myeloid
| Article | Year |
|---|---|
Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia cells.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Cyclophosphamide; Cytotoxicity, Immunologic; Drug Synergism; Humans; Immunotherapy, Adoptive; Interleukin-2; Leukemia, Myeloid; T-Lymphocytes, Regulatory; Tumor Cells, Cultured | 1994 |
Bone marrow purging, 4-hydroperoxycyclophosphamide, and the FDA.
Topics: Acute Disease; Bone Marrow; Bone Marrow Purging; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Industry; Drug Utilization; Ethics, Medical; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Neoplasm, Residual; Treatment Outcome; United States; United States Food and Drug Administration | 1993 |
Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome.
Topics: Acute Disease; Carmustine; Cyclophosphamide; Cytarabine; DNA Repair; Doxorubicin; Drug Resistance; Ethylnitrosourea; Glutathione; Guanine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphocytes; Treatment Outcome | 1994 |
Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Bone Marrow Purging; Cryopreservation; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Female; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Macrophages; Male; Middle Aged; Remission Induction | 1993 |
Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis.
Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Purging; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Feasibility Studies; Female; Humans; Itraconazole; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Premedication; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous | 1996 |
Quantitative and qualitative alterations of long-term culture-initiating cells in patients with acute leukaemia in complete remission.
Topics: Acute Disease; Antineoplastic Agents; Bone Marrow Purging; Cyclophosphamide; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Transplantation, Autologous | 1998 |
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Topics: Acute Disease; Antigens, CD34; Antineoplastic Agents; Blood Cells; Bone Marrow Purging; Cell Division; Coculture Techniques; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Neoplastic Stem Cells | 2001 |